Entera Bio Ltd. financial data

Symbol
ENTX on Nasdaq
Location
Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, Israel
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 988 % +41.5%
Debt-to-equity 14.1 % -27%
Return On Equity -82.9 % +17.4%
Return On Assets -72.6 % +13.6%
Operating Margin -6.38K % +57.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +25.7%
Common Stock, Shares, Outstanding 45.5M shares +25.2%
Entity Public Float 58.8M USD +184%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 46.8M shares +26.3%
Weighted Average Number of Shares Outstanding, Diluted 46.8M shares +26.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 166K USD +191%
Cost of Revenue 166K USD +246%
Research and Development Expense 5.32M USD +27%
General and Administrative Expense 5.27M USD +19.3%
Operating Income (Loss) -10.6M USD -23.5%
Nonoperating Income (Expense) 1K USD -98.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.02M USD -28.6%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -10.6M USD -24.2%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.9M USD +19.9%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 192K USD +187%
Assets, Current 19.3M USD +101%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 79K USD +3.95%
Operating Lease, Right-of-Use Asset 190K USD -44.8%
Assets 19.7M USD +96%
Accounts Payable, Current 383K USD +455%
Liabilities, Current 1.84M USD +42.5%
Operating Lease, Liability, Noncurrent 9K USD -95%
Liabilities 2.41M USD +60.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 41K USD 0%
Retained Earnings (Accumulated Deficit) -119M USD -9.77%
Stockholders' Equity Attributable to Parent 17.3M USD +102%
Liabilities and Equity 19.7M USD +96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.4M USD +24.6%
Net Cash Provided by (Used in) Financing Activities 13.3M USD +44357%
Net Cash Provided by (Used in) Investing Activities -8K USD
Common Stock, Shares Authorized 140M shares 0%
Common Stock, Shares, Issued 45.5M shares +25.2%
Common Stock, Par or Stated Value Per Share 0 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19M USD +108%
Deferred Tax Assets, Valuation Allowance 20.9M USD +7.2%
Deferred Tax Assets, Gross 20.9M USD +7.12%
Operating Lease, Liability 272K USD -30.3%
Depreciation 8K USD -38.5%
Payments to Acquire Property, Plant, and Equipment 8K USD
Lessee, Operating Lease, Liability, to be Paid 301K USD -33.7%
Operating Lease, Liability, Current 194K USD +25.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 101K USD -45.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 198K USD +7.61%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29K USD -54.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2K USD -97.7%
Deferred Tax Assets, Operating Loss Carryforwards 19.2M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 83K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%